Libtayo and dosage: Strength, form, how it's given, and more Health ConditionsHealth ConditionsAlzheimer's & DementiaAnxietyArthritisAsthma & AllergiesBreast CancerCancerCardiovascular HealthCOVID-19Dermatology & SkincareDiabetesEnvironment & SustainabilityExercise & FitnessEye HealthHeadache & MigraineHealth EquityHIV & AIDSHuman BiologyInflammatory Bowel DiseaseLeukemiaLGBTQIA+Men's HealthMental HealthMultiple Sclerosis (MS)NutritionParkinson's DiseasePsoriasisSexual HealthWomen's HealthDiscoverNewsLatest NewsOriginal SeriesMedical MythsHonest NutritionThrough My EyesNew Normal HealthPodcastsHow to understand chronic painWhat is behind vaccine hesitancy?The amazing story of hepatitis C, from discovery to cureNew directions in dementia researchCan psychedelics rewire a depressed, anxious brain?Why climate change matters for human healthToolsGeneral HealthDrugs A-ZHealth HubsHealth ToolsBMI Calculators and ChartsBlood Pressure Chart: Ranges and GuideBreast Cancer: Self-Examination GuideSleep CalculatorHealth ProductsAffordable Therapy OptionsBlood Pressure MonitorsDiabetic SuppliesFitness TrackersHome GymsGreen Cleaning ProductsHow to Shop for CBDQuizzesRA Myths vs FactsType 2 Diabetes: Managing Blood SugarAnkylosing Spondylitis Pain: Fact or FictionConnectAbout Medical News TodayWho We AreOur Editorial ProcessContent IntegrityConscious LanguageNewslettersSign UpFollow UsMedical News TodayHealth ConditionsDiscoverToolsConnectSubscribe Libtayo dosageMedically reviewed by Tanya Kertsman, PharmD — By Jennifer Mitri Williamson, Pharm.D. on June 11, 2022 OverviewLibtayo (cemiplimab-rwlc) is a brand-name prescription drug. The Food and Drug Administration (FDA) has approved it to treat specific types of cancer, including:locally advanced or metastatic* skin cancer, such as: cutaneous squamous cell carcinomabasal cell carcinoma†certain types of locally advanced or metastatic non-small cell lung cancer Your doctor may prescribe this drug if you have already tried other medications to treat your specific cancer. Libtayo belongs to a group of drugs called programmed death receptor-1 blockers. It’s also a biologic drug. At this time, there are no biosimilar versions of Libtayo available. It’s only available as a brand-name drug. This medication comes as a solution that’s given by IV infusion by a doctor or another healthcare professional. You’ll receive your infusion at a doctor’s office, hospital, or infusion site. * Locally advanced and metastatic cancers are cancers that have spread to other areas of your body. † For this use, Libtayo received accelerated approval from the FDA. Accelerated approval is based on the results of early clinical trials of the drug. The FDA will decide on full approval of Libtayo for this use after more trials have been completed. Dosage summary The following chart summarizes Libtayo’s dosage. Your doctor will determine the dosage that’s best for you.FormStrengthDosingsolution given by IV infusion350 milligrams per 7 milliliters of solution (mg/mL)350 mg every 3 weeks, given over 30 minutes For information about Libtayo’s dosing and administration, keep reading. For a comprehensive look at Libtayo, see this article. This article describes typical dosages for Libtayo provided by the drug’s manufacturer. However, your doctor will prescribe the Libtayo dosage that’s right for you. Libtayo dosage Below is information about Libtayo dosage for its approved uses. Libtayo form Libtayo comes as a solution in a vial. The solution is given by IV infusion by your doctor or another healthcare professional. You’ll receive your infusion at your doctor’s office, a hospital, or an infusion site. Libtayo strength Libtayo only comes in one strength: 350 milligrams per 7 milliliters of solution (mg/mL). Typical dosages Your doctor will recommend the best dosage of Libtayo for you. They will ultimately prescribe the smallest dosage that provides the desired effect. The following information describes dosages that are commonly used or recommended. However, be sure to take the dosage your doctor prescribes for you. Your doctor will determine the best dosage to fit your needs. Dosage for cutaneous squamous cell carcinoma To treat certain types of locally advanced or metastatic cutaneous squamous cell carcinoma, the recommended Libtayo dosage is 350 mg every 3 weeks. Dosage for basal cell carcinoma For treating certain types of locally advanced or metastatic basal cell carcinoma, the recommended dosage of Libtayo is 350 mg every 3 weeks. Dosage for non-small cell lung cancer To treat certain types of locally advanced or metastatic non-small cell lung cancer, the recommended Libtayo dosage is 350 mg every 3 weeks. Long-term treatment Libtayo is meant to be used as a long-term treatment. If you and your doctor determine that Libtayo is safe and effective for you, you’ll likely take it long term. How Libtayo is given Libtayo comes as a solution that’s given by IV infusion (an injection through a vein over time). Your doctor or another healthcare professional will give your dose of Libtayo. It’s typically given over 30 minutes. If you notice any side effects from the drug, tell your doctor right away. These side effects may happen during or after the infusion. Your doctor may recommend slowing down, pausing, or even stopping your infusion. This will depend on the type of side effects that you have. (To learn about the side effects of Libtayo, see this article.) Missed dose If you miss your appointment for your Libtayo infusion, call your doctor’s office. They’ll reschedule your appointment as soon as possible. It’s important not to miss your Libtayo infusion appointments. If you do not get your dose every 3 weeks, Libtayo may not work as well as it should to treat your cancer. To help make sure that you don’t miss an infusion appointment, try using a medication reminder. This can include setting an alarm or using a timer. You could also download a reminder app on your phone. Takeaway and helpful resources The dosages in this article are typical dosages provided by the drug’s manufacturer. If your doctor recommends Libtayo for you, they will prescribe the dosage that’s right for you. If you have questions about the dosage of Libtayo that’s best for you, talk with your doctor. Besides learning about dosage, you may want other information about Libtayo. These additional articles might be helpful:More about Libtayo. For information about other aspects of Libtayo, refer to this article.Side effects. To learn about side effects of Libtayo, see this article. You can also look at the Libtayo prescribing information.Details about your condition.For details about skin cancer, see our cancer hub as well as this list of dermatology articles.For information about lung cancer, our lung cancer hub and these related articles might be helpful. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Last medically reviewed on June 11, 2022Lung CancerCancer / OncologyMelanoma / Skin CancerPharmacy / PharmacistDrugsMedically reviewed by Tanya Kertsman, PharmD — By Jennifer Mitri Williamson, Pharm.D. on June 11, 2022 Latest newsWhat sets 'SuperAgers' apart? Their unusually large neuronsOmega-3 may provide a brain boost for people in midlifeSeasonal affective disorder (SAD): How to beat it this fall and winterCDC: Monkeypox in the US 'unlikely to be eliminated in the near future'Why are more women prone to Alzheimer's? New clues arise Related CoverageThe best cancer-fighting foodsMedically reviewed by Katherine Marengo LDN, R.D. Cancer-fighting foods include apples, berries, and fatty fish. These foods may help prevent cancer and promote general health. Learn more about the…READ MOREWhat coverage does Medicare provide for skin cancer?Medically reviewed by Deborah Weatherspoon, Ph.D., MSN Medicare provides a broad range of coverage for cancer care, including skin cancer. Out-of-pocket costs may apply. Read on for more information.READ MOREWhen are rashes a sign of cancer?Medically reviewed by Owen Kramer, MD A rash can indicate mild irritation, or it could be a sign of skin cancer. It is important to find out the differences between cancerous and…READ MOREWhat to know about metastatic lung cancerMedically reviewed by Adithya Cattamanchi, M.D. In this article, learn how and where lung cancer spreads, or metastasizes, and the effects on the body. We also describe prevention and a person's…READ MORESmall cell vs. non-small cell lung cancerMedically reviewed by Seunggu Han, MD The two main types of lung cancer are small cell and non-small cell lung cancer. Learn about the symptoms, diagnosis, treatments, and outlook for each…READ MORE